title: Misconceptions and facts about treating hypertension.
abstract: Hypertension is a powerful risk factor strongly linked to adverse cardiovascular outcomes. Because of its high prevalence, health care providers at many levels are involved in treating hypertension. Distinct progress has been made in improving the rates of hypertension awareness and treatment over years, but the overall control of hypertension remains inadequate. Several recent guidelines from different sources have been put forward in an attempt to bridge the gap between existing evidence and clinical practice. Despite this effort, several misconceptions about treating hypertensive cardiovascular disease continue to persist among clinicians. This review highlights some of the misconceptions regarding antihypertensive therapy.
authors.affiliation: Mt Sinai St Luke's and Roosevelt Hospitals, New York, NY. Electronic address: eargulian@chpnet.org.
authors.forename: Edgar
authors.initials: E
authors.lastname: Argulian
authors.affiliation: The Chaim Sheba Medical Center, Tel Hashomer, Israel.
authors.forename: Ehud
authors.initials: E
authors.lastname: Grossman
authors.affiliation: Mt Sinai St Luke's and Roosevelt Hospitals, New York, NY.
authors.forename: Franz H
authors.initials: FH
authors.lastname: Messerli
mesh_terms: D000959:Antihypertensive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002752:Chlorthalidone / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D006973:Hypertension / Q000188:drug therapy* / Q000517:prevention & control; D007190:Indapamide / Q000627:therapeutic use; D012307:Risk Factors; D049993:Sodium Chloride Symporter Inhibitors / Q000627:therapeutic use
chemical_list: D000959:Antihypertensive Agents; D049993:Sodium Chloride Symporter Inhibitors; D006852:Hydrochlorothiazide; D007190:Indapamide; D002752:Chlorthalidone
keywords: Antihypertensive therapy; Hypertension; J-curve